The study, under version 1.0 of the protocol, was known as FLU 004. Under version 2.0, the protocol was expanded to allow co-enrollment in other qualifying INSIGHT studies and will now be referred to as INSIGHT Genomics.

The purpose of the current protocol is to obtain a whole blood sample from which DNA willbe extracted to study polymorphisms in immune response genes and other genetic variants that may be associated with an increased risk of disease progression among individuals with infectious diseases of public health importance who are first enrolled in a qualifying INSIGHT study.